BIOA
BioAge Labs, Inc
NASDAQ: BIOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.85
-0.06% today
Updated 2026-04-30
Market cap
$756.98M
P/E ratio
—
P/S ratio
84.16x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$4 – $24
Volume
0.5M
BioAge Labs, Inc (BIOA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.67M | $1.54M | $2.17M | $8.27M | $14.94M | $0.00 | $0.00 | $0.00 | $8.99M |
| Revenue growth (YoY) | — | -42.1% | +40.8% | +280.9% | +80.6% | -100.0% | — | — | — |
| Cost of revenue | $2.69M | $6.04M | $2.61M | $13.67M | $22.32M | — | — | — | $213000.00 |
| Gross profit | $-23782.00 | $-4.50M | $-440828.00 | $-5.39M | $-7.38M | — | — | — | $8.99M |
| Gross margin | -0.9% | -291.7% | -20.3% | -65.2% | -49.4% | — | — | — | 100.0% |
| R&D | $16.58M | $15.16M | $20.29M | $7.20M | $5.47M | $30.52M | $33.89M | $59.04M | $73.97M |
| SG&A | $5.03M | $6.17M | $6.59M | $6.54M | $10.41M | $9.45M | $14.51M | $19.16M | $27.81M |
| Operating income | $-41.18M | $-35.20M | $-38.53M | $-29.63M | $-110.01M | $-39.97M | $-48.40M | $-78.19M | $-92.78M |
| Operating margin | -1545.1% | -2281.5% | -1773.9% | -358.2% | -736.2% | — | — | — | -1031.5% |
| EBITDA | $-38.84M | $-44.98M | $-33.07M | $-13.29M | $-88.72M | $-39.35M | $-55.90M | $-68.58M | $-92.78M |
| EBITDA margin | -1457.4% | -2915.0% | -1522.6% | -160.7% | -593.7% | — | — | — | -1031.5% |
| EBIT | $-40.55M | $-46.35M | $-37.23M | $-22.45M | $-98.07M | $-39.48M | $-56.06M | $-68.74M | $-92.99M |
| Interest expense | $7.43M | — | — | — | — | $241000.00 | $7.79M | $2.37M | $697000.00 |
| Income tax | $102794.00 | $75371.00 | $-3786.00 | $25646.00 | $81735.00 | $241000.00 | $7.79M | $-71.11M | — |
| Effective tax rate | -0.3% | -0.2% | 0.0% | -0.1% | -0.1% | -0.6% | -13.9% | 50.0% | 0.0% |
| Net income | $-33.22M | $-46.42M | $-37.23M | $-22.48M | $-98.15M | $-39.72M | $-63.85M | $-71.11M | $-80.61M |
| Net income growth (YoY) | — | -39.8% | +19.8% | +39.6% | -336.7% | +59.5% | -60.8% | -11.4% | -13.4% |
| Profit margin | -1246.3% | -3008.5% | -1713.9% | -271.7% | -656.8% | — | — | — | -896.1% |